This volume of Current Opinion in Immunology: Lymphocyte Effector Functions highlights lymphocytes or lymphocyte functions that often fall outside the mainstream of immunological research. First, although CD4+ regulatory T cells (Tregs) have been studied extensively, CD8+ cells having similar functions have also been noted [1,2]. As reviewed in the first article in this volume by Jerry Niederkorn, these cells can prove critical in maintaining tolerance in certain organs and under particular conditions, including the normal eye, patients with multiple sclerosis, and in mice, in certain lung tumors and perhaps in chemically induced carcinomas as well. In the second article, Frances Lund has reviewed results from many studies pointing to the importance of B cells as producers of cytokines [3], apart from their role as the source of immunoglobulin. B cells producing type I (Be-1 cells), type 2 (Be-2 cells), and suppressive cytokines (Bregs) have been noted, most of which appear to arise from follicular B cells. The appreciation of such “effector B cells” is particularly timely in that B cell depletion as a therapy for various autoimmune disorders has now become common. In the third article, reports on the development of cytolytic T cells expressing CD4 rather than CD8 are reviewed for the human system by Rene van Lier. Though such cells have been noted in both mice and humans, Dr. van Lier summarizes evidence that in humans, the role of cytomegalovirus in promoting the development of CD4+ cytolytic T cells appears to be critical [4]. In the fourth article, recent findings concerning NK cells as lymphocyte effectors in the human system are reviewed by Yenan Bryceson and Eric Long. Activating and inhibitory receptors that have been identified thus far are tabulated, and recent findings examined for how these various signals are integrated within a given NK cell [5]. The fifth article focuses on a flurry of reports published in the last 2–3 years from different sources, showing that in various disease models in which T cells producing IL-17 appear to be of particular importance, the IL-17+ T cells are in large part represented by γδ T cells, rather than the CD4+ Th-17 cells that have been fairly extensively studied [e.g. [6]]. As summarized here in a review by Christina Roark et al., several different γδ T cell subsets have been found to produce IL-17. Moreover, differences between IL-17-producing γδ T cells and Th17 cells suggest that the two cell types are likely elicited via different mechanisms, and that the γδ T cells provide an early source of IL-17. Finally, the many functions that have been attributed to iNKT cells, as likened to the many functions of a Swiss army knife, are summarized in a sixth review by Laurent Gapin et al. This comprehensive article includes a succinct overview of the characteristics of iNKT cells, and outlines new findings concerning their development [e.g. [7]}. Plausible mechanisms for how a given cell type could have so many different functions are also put forth.
In addition to the roles of more conventional lymphocytes, potential roles of unconventional lymphocytes should also be assessed in the study of any given immune response or disorder. The reviews in this volume will be helpful in suggesting other cell types that, though less-appreciated, may also be potential players in a particular disease or condition.
Biography
Rebecca O’Brien is Professor of Immunology in the Integrated Department of Immunology, National Jewish Medical and Research Center, Denver, USA. She received graduate training as an immunologist at the University of Washington in Seattle, USA, followed by postdoctoral work at National Jewish. Her research focuses on γδ T cells, with an emphasis on their functional roles and the specificity of the γδ T cell receptor.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Kosiewicz MM, Streilein JW. Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells. J Immunol. 1996;157:1905–1912. [PubMed] [Google Scholar]
- 2.Niederkorn JY. Regulatory T cells and the eye. Chem Immunol Allergy. 2007;92:131–139. doi: 10.1159/000099263. [DOI] [PubMed] [Google Scholar]
- 3.Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000;1:475–482. doi: 10.1038/82717. [DOI] [PubMed] [Google Scholar]
- 4.van Leeuwen EM, Remmerswaal EB, Heemskerk MH, ten Berge IJ, van Lier RA. Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. Blood. 2006;108:3121–3127. doi: 10.1182/blood-2006-03-006809. [DOI] [PubMed] [Google Scholar]
- 5.Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 2006;107:159–166. doi: 10.1182/blood-2005-04-1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Roark CL, French JD, Taylor MA, Bendele AM, Born WK, O’Brien RL. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing γδ T cells. J Immunol. 2007;179:5576–5583. doi: 10.4049/jimmunol.179.8.5576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Matsuda JL, Zhang Q, Ndonye R, Richardson SK, Howell AR, Gapin L. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood. 2006;107:2797–2805. doi: 10.1182/blood-2005-08-3103. [DOI] [PMC free article] [PubMed] [Google Scholar]